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Abstract  
Earlier detection of diseases reduces the mortality rate.  So the development of better screening techniques could be 
considered as a main topic of interest. In non-invasive medical imaging, specifically in  Magnetic Resonance 
Imaging (MRI), conventional contrast agents do not have a good performance in imaging of some fine parts. The 
prosperity of preclinical researches in oncology that purpose at developing and evaluating curative strategies on 
samples, requires effective new functionalized contrast agents for portrayal tumor growth, monitoring the trace of a 
treatment and/or inducing the demolition of cancerous tumors. This study was performed by searching 
Nanotechnology, Molecular imaging, magnetic nanoparticles, and contrast agent nanoparticles keywords in Google 
scholar, Science direct, PubMed and Scopus websites in terms of content. We reviewed the recent studies about 
development of nanoparticles as contrast agents for medical imaging because they have a longer vascular half-life 
than molecular contrast agents. It could be indicate that nanoparticles are important items in increasing the contrast 
of the images so that even reducing the size of the magnetic nanoparticles escalates the contrast and half-life of the 
particles. Particles with a diameter of 10 nm have a greater half-life than particles with a diameter of 30 nm or 
larger. It was also found that to removing material defects or improve their biocompatibility; particles should be 
covered with other materials or doped with metals. 
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A comprehensive explanation of molecular 
imaging is “the description, visualization and 
measurement of biological procedures at the 
molecular and cellular rank in human and other 
living systems [1]. Hence, such molecular imaging 
provides information that is outside regional anatomy 
and physiology regarding tissue structure and 
molecular changes in tissues. Although, among the 
imaging devices, living systems (MRI) has relatively 
low sensibility for detecting real molecular changes, 
but it’s based on the phenomenon of magnetic 
resonance of core with the appropriate contrast 
factor, supply early diagnosis of cancer and various 
kinds of diseases, also does not use ionizing radiation . 
The MRI is based on the interaction between the 
magnetic field and the tissue protons [2]. In the MRI, 
magnetic forum directs the protons' magnetic moments 
in the parable. By generating the resonance frequency 
and transmitting energy to the proton at a RF1 and 
through rotating the magnetic moments of the protons, 
removes them from the Z axis and is positioned at an 
angle which named the flip angle. The magnetic 
moments of the proton will be restor to the first state 
by removing the RF [3.4]. The signal strength that 
occurs in MRI depends on both the density of the 
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protons and the rest times of T1 and T2. T1 (spin-
lattice; scilicet, magnetized in the direction of the 
static magnetic field) is the time when 63% of the 
longitudinal magnetic moments of a proton after the 
excitation are returned from the vertical direction to 
the parallel of the magnetic field. Also, T2 (spin-
spin; crossover to the static magnetic field) is the 
time when the transverse magnetic moment of a 
proton after an excitation decreases to 37% of its 
original value. Protons that quickly find comfort, 
have a short T1, and produce high-intensity signals 
[4]. In most tissues, the inherent changes of T1 and 
T2 are slight, so, in clinical applications, outward 
materials are often used to increase the contrast 
between the target tissue and other nearby tissues 
.The T1 contrast factors are used to gain the signal 
strength, which increases the positive contrast in the 
images, while the T2 contrast factors reduce the 
intensity of the signal and result in a negative 
contrast increment in the image[5]. 
         The contrast media in MRI are divided into 
paramagnetic and supra magnetic groups. Super 
paramagnetic materials containes metal ions (Co2+, 
Cu2+and specially Fe2+/Fe3+) reduce the comfort of 
adjacent hydrogen protons. At present, most of the 
contrast agents used in the clinic is according to the 
paramagnetic chelates of lanthanide metals (Eu3+, 
Ho3+, Dy3+ and specially Gd3+). Although 
gadolinium chelates are widely used, their short flow 
time, poor traceability and toxicity dependence have 
led to the continuous extension of magnetic 
nanoparticles as contrast enhancers [6].  
          Today, in clinical work, nanoparticles used to 
improve the contrast of MRI images. In addition, 
special coatings utilized to increase their efficiency. 
The coating material surrounding core of the 
nanoparticles affects the relaxivity, chemical 
stability, biocompatibility, bio distribution, and blood 
half-life of the nanoparticles [7,8]. 
          Figure 1 is an example of a core iron 
nanoparticle and its side effects in diagnostic and 
therapeutic applications [9]. 
Figure 1: Schematic view of nanoparticles with the characteristics of 
nuclear material particles including Surface particles, good magnetic 
properties, stability in aqueous solutions and physiological liquids with 
appropriate coatings [9]. 
         This study is a theoretical review study that was 
performed by searching Nanotechnology, Molecular 
imaging, magnetic nanoparticles, and contrast agent 
nanoparticles keywords in Google scholar, Science 
direct, PubMed and Scopus websites in terms of 
content .This article was written based on 10 chosen 
articles which were found after the search in the 
mentioned databases. 
          We summarized the cases that affect the contrast 
of MRI. Briefly Super paramagnetic and paramagnetic 
particles, which are generally based on iron and 
gadolinium, with their small structures, reduce the 
time of T1 and T2, which will darken the image field 
and increase the contrast and sensitivity. 
Various types of super 
paramagnetic iron oxide 
(SPIO magnetic nanoparticles: 
       The only difficulty of 1-Single-crystalline 
monoxide nanoparticles (MION) and cross-linked iron 
oxide (CLIO) methods is low solvability in water. 
Therefore, different coatings types used to solve this 
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problem. These particles are dextran-coated, have a 
longer half-life and are more capable of binding to 
active biochemical molecules, so they are better for 
medical applications in in-situ conditions. The size of 
the center of iron oxide is 2.8nm and the size of the 
dextran coating is about 10nm-30nm [10]. 
        Magneto ferritin (MFe2O4): Ferritin is a 
protein that stores iron in the body. Magnetifritin is 
also used in imaging, and the T2 has a serum level of 
about 157 L mmol-1 s-1 and acceptable 
biocompatibility and colloidal stability are expected 
in the blood. But the results showed the clearing of 
less than 10 minutes for these particles, because they 
are transmitted by the reticulanal ductal system to the 
liver, spleen, and lymph nodes, and so are 
appropriate for imaging these organs, but not suitable 
for molecular imaging [10]. 
        Magneto dendrimer: The multifunctional 
structure through the end groups and ventricular units 
makes dendrimers optimal for drug delivery, which 
can also carry magnetic nanoparticles; these particles 
exhibit more magnetic properties (magnetic 
saturation around 94emu g_1 Fe ) and a high T2 
comfort level of 200 to 406 mM-1 s-1 and easily 
penetrates into the cell without the need for a 
transient agent. In this way, these factors can be used 
for cell marking and cell tracking. The size of the 
iron oxide core reaches 8nm-7nm and the core comes 
with a dendriform coating of 20nm-30nm [10]. 
       Magneto liposome: Liposomes also used to 
convey drug substances and provide a good coating 
for the hydrophilicity of magnetic nanoparticles. The 
particles placed in the center of the liposome, whose 
oxide iron core size is 16 nm, the particle size in the 
liposomal state is about 60 nm, and in this structure, 
the T2 is 240 mM-1 s-1 [10]. 
       SPIO nanoparticles can be further functionalized 
by surface coating using proteins, peptides, 
antibodies, polymers (polyethylene glycol, PEG), 
carbohydrates (dextran, chitosan), aptamers, DNA, 
RNA, and oligosaccharides [11]. 
       So far, different types of coating materials, 
including dextran [8], carboxydextran [12], 
carbohydrate-polyethylene glycol [8], and citrate [13, 
14], have been used for MRA and perfusion were 
studies. 
           Polyethylene glycol (PEG) is a polymeric 
surfactant, which used as the iron oxide nanoparticles 
coating material because of its high solubility and 
biocompatibility; also, many studies show that in 
aqueous solutions, it has not any damage to protein 
conformation or enzymatic activity. Therefore, its 
stability in aqueous solutions, and prolonged blood 
flow time considered as the good properties to use it as 
the coating agent. 
         PEG can decrease or prevent opsonization of the 
nanoparticles. On the other hand, carboxydextran is a 
biocompatible organic polymer, which decreases the 
occurrence of allergic reactions and has a long 
circulation time in blood. The long blood half-life of 
both coated nanoparticles provides enough time for 
acquisition of imaging data [15]. 
          Among the numerous small bio-molecules, 
phosphorylated form of pyridoxal which founds in 
vitamin B6 [ pyridoxal 5′-phosphate (PLP)], is a 
hopeful molecule to coat and target nanoparticles 
Indeed, PLP-coated Iron Oxide Nanoparticles 
(IONPs)could make the T 2 shortening capabilities 
less effectual [16]. 
          Recently, researchers developed a new synthesis 
protocol for iron/iron-oxide shell/ core nanoparticles 
(Fe NP) with superior magnetic attributes which 
convert into greater T2 relaxivity in MRI with a 
similarly low cytotoxicity when compared to IONP of 
similar size (16 nm) and coated with the same 
molecule, dimercaptosuccinic acid[17-18]. Figure2 
shows the some types of surface coatings of 
nanoparticles [19]. 
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Figure 2: A: Orientation of polymer in the form of string, B: The layers of polymer that completely encapsulate the nanoparticles (dextran and PEG), 
C: Phospholipid double layer membrane, D: Core-shell structure (Au), E: The doping nanoparticles are covered in this way. 
 
 
         Paramagnetic: Gadolinium (Gd) is a popular 
paramagnetic contrast agent, which its inherent 
toxicity neutralized by using it in a chelated form 
such as gadolinium diethylenetriaminepentaacetic 
acid (Gd-DTPA) or gadolinium 
tetraazacyclododecane tetra acetic acid; Gd-DOTA. 
Owning to its ability to shorten T1, it makes 
enhanced MRI images. Gadolinium-containing 
nanoparticles have been shown to have a high 
relaxivity on MRI, either as the core material of the 
particle or as an element of the outer coating [20]. 
         Nanoparticles are contributing enhancers of 
contrast, and with its own characteristics, enhance 
the quality of the images. Gadolinium chelates have 
been affixed on latex, dendrimers, polymers, 
liposomes, micelles and metals like gold or silica 
nanoparticles. In almost all cases, the same pattern of 
nuclear magnetic relaxation distribution profile is 
discoveres with low relaxivity values at high fields 
and a significant increase in relaxivity for the middle 
magnetic fields. In one case geometrical restriction 
of gadolinium chelates can strongly rise their 
longitudinal relaxivity, if gadolinium loaded as 
freights into altered nano-objects such as mesoporous 
silica, carbon nanotubes or liposomes. The 
nanoparticles have been evaluated previously for 
medical applications with gadolinium chelates that 
affixed on or loaded into it. Hybrid core shell 
nanoparticles made of a crystalline core, based on 
gadolinium or doped with gadolinium (nanoparticles 
are gadolinium oxide (Gd2O3), GdF3, NaYF4:Er3, 
Yb3+ and Gd3+ among others) [20.21]. 
Groups of these factors, which are at least 10 
times more effective than the best available current 
agents, are nano-diamonds. Nano-diamonds have a 
high self-efficacy to absorb water molecules, which 
improves the properties of the gadolinium- (III) nano 
diamonds complex [22]. 
Nanotube and fullerene C80 are other agents 
that act like nano diamonds and serve as a fence for 
gadolinium ions. These factors have a greater effect 
on the images than nano diamonds images and 
increase the magnitude of magnetic imaging signals 
by 40 times. In the form of a gadonano tube, the 
gaudillinum chelated or chemically bonded to 
another compound [23]. 
Other types of nanoparticles are Gd2O3 
(based on gadolinium crystalline core) that is known 
as a less toxic contrast agent with better contrast 
capability [24]. Also, to increase the efficiency of 
these nanoparticles, it is doped with an other 
elements such as the lanthanide group: Neodymium 
doped with gadolinium oxide nanoparticles 
(Nd/Gd2O3), Diethyl glycol doped with gadolinium 
oxide nanoparticles (DEG/ Gd2O3) [25]. 
MRI examinations linked to ICP analysis, 
display that - Gold nanoparticles coated with 
dithiolated diethylenetriamine pentaacetic acid-
gadolinium chelate;Au@DTDTPA-Gd  nanoparticles 
can be used as in vivo contrast agents for MRI. 
Regardless of the low content in gadolinium (5 mm) 
and in gold (10 mg·mL-1), the particles were simply 
discovered. Their capability to freely spread in the 
blood pool without unpleasant reposition in the 
lungs, liver, and spleen, mid the fact that they can be 
followed up by MRI, is very absorbing for specific 
targeting because the reposition would derive from 
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only the particular interaction between the targets 
existing in the part of interest and the bio targeting 
groups on the particles [26]. 
Studies show that, PEG enduring two 
phosphate groups on the same side as a cover for 
water-soluble NaGdF4 nanocrystals, display higher 
T1 relaxivity than Gd-DTPA and supreme colloidal 
solidity in water and PBS buffer. In addition, a 
sequence of in vivo examinations was performed by 
using magnetic resonance imaging technique to 
detect intraperitoneal tumor xenografts in nude mice. 
The result showed that the NaGdF4–PEG-mAb 
excavator had forceful MR contrast enhancement 
signs and good tumor-specific targeting ability [27]. 
         Taken together, these data supply powerful 
evidences that propose the improved contrast 
increment by Fe NP, which can improve the 
detection of small tumors. Fe NPs characterized here 
gain the sensitivity, specificity and nicety of tumor 
detection for unenhanced MRI, or contrast increment 
with IONP. Table 1 summarizes some of the 




Table1. Magnetic nanoparticle coatings and their results. 
Covering material Advantages Result   
Acid: 
Citric,gluconic,oleic 
A large SPIO core with a thin coating of organophilic composition    
Polymers: 
1. Dextran 









1.High half-life of the plasma 
2.Reduce diameter, increase plasma half-life 
3.Long half-life in the blood plasma 
4.Biocompatibility, bioavailability and stable pH, along with surface 
modification 
5.Carrier of magnetic drug delivery 
6.Biocompatible coverage approved by the Food and Drug Administration 
7.Increased half-life in blood plasma, the ability to change surface chemistry 
8.Thin coating and bio extensions available 
 
Super-paramagnetic iron oxide nanoparticles coated with dextran are 
non-toxic for dendritic cells and macrophages derived from 
monocytes. 
 
Targeted drug delivery and increased nanoparticle stability 
 
  
PAM Matrix with the ability to trap multiple particles    
Silane The reaction is related to alcohol and the coupling agent of silane    
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Conclusion 
         It could be understood that nanoparticles are 
important items in increasing the contrast of the 
images so that even reducing the size of the magnetic 
nanoparticles escalates the contrast and half-life of 
the particles. Particles with a diameter of 10 nm have 
a greater half-life than particles with a diameter of 30 
nm or larger. It was also found that to removing 
material defects or improve their biocompatibility; 
particles should be cover with other materials or 
doped with metals. 
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